Home » Carl Icahn Sues Amylin Pharmaceuticals, Pushes for Sale
Carl Icahn Sues Amylin Pharmaceuticals, Pushes for Sale
Carl Icahn sued Amylin Pharmaceuticals to block enforcement of a bylaw that prevents the billionaire investor from launching a proxy fight that could lead to a sale of the maker of diabetes drugs.
International Business Times
International Business Times
Upcoming Events
-
07May
-
14May
-
30May